Konidaris Tasos, Executive Vice President and CFO of Amneal Pharmaceuticals ($AMRX), sold shares on the open market three times in the last year, totaling $4.7 million. His most recent sale occurred on August 15, 2025. These sales rank 2,037th among 11,678 insiders in our database, where the average is $8.6 million across about 6.4 transactions per insider. Tasos made no open market purchases during this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 3, 2026 | Amneal Pharmaceuticals, Inc. | $AMRX | Konidaris Tasos | Executive Vice President & CFO | M | Restricted Stock Units | 28538 | $0.00 | 85,617.0000 | 324,754,000 | 25.00% | 0.01% |
| March 3, 2026 | Amneal Pharmaceuticals, Inc. | $AMRX | Konidaris Tasos | Executive Vice President & CFO | M | Restricted Stock Units | 45290 | $0.00 | 0.0000 | 324,754,000 | 100.00% | 0.01% |
| March 4, 2026 | Amneal Pharmaceuticals, Inc. | $AMRX | Konidaris Tasos | Executive Vice President & CFO | F | Class A Common Stock | 22035 | $13.30 | 449,434.0000 | 324,754,000 | 4.67% | 0.01% |
| March 4, 2026 | Amneal Pharmaceuticals, Inc. | $AMRX | Konidaris Tasos | Executive Vice President & CFO | M | Class A Common Stock | 43982 | $0.00 | 471,469.0000 | 324,754,000 | 10.29% | 0.01% |
| March 3, 2026 | Amneal Pharmaceuticals, Inc. | $AMRX | Konidaris Tasos | Executive Vice President & CFO | F | Class A Common Stock | 229817 | $13.31 | 427,487.0000 | 324,754,000 | 34.96% | 0.07% |
| March 3, 2026 | Amneal Pharmaceuticals, Inc. | $AMRX | Konidaris Tasos | Executive Vice President & CFO | M | Class A Common Stock | 458716 | $0.00 | 657,304.0000 | 324,754,000 | 230.99% | 0.14% |
| March 3, 2026 | Amneal Pharmaceuticals, Inc. | $AMRX | Konidaris Tasos | Executive Vice President & CFO | F | Class A Common Stock | 14298 | $13.31 | 198,588.0000 | 324,754,000 | 6.72% | 0.00% |
| March 3, 2026 | Amneal Pharmaceuticals, Inc. | $AMRX | Konidaris Tasos | Executive Vice President & CFO | M | Class A Common Stock | 28538 | $0.00 | 212,886.0000 | 324,754,000 | 15.48% | 0.01% |
| March 3, 2026 | Amneal Pharmaceuticals, Inc. | $AMRX | Konidaris Tasos | Executive Vice President & CFO | F | Class A Common Stock | 24251 | $13.31 | 184,348.0000 | 324,754,000 | 11.63% | 0.01% |
| March 3, 2026 | Amneal Pharmaceuticals, Inc. | $AMRX | Konidaris Tasos | Executive Vice President & CFO | M | Class A Common Stock | 57339 | $0.00 | 208,599.0000 | 324,754,000 | 37.91% | 0.02% |
| March 3, 2026 | Amneal Pharmaceuticals, Inc. | $AMRX | Konidaris Tasos | Executive Vice President & CFO | F | Class A Common Stock | 16182 | $13.31 | 151,260.0000 | 324,754,000 | 9.66% | 0.00% |
| March 3, 2026 | Amneal Pharmaceuticals, Inc. | $AMRX | Konidaris Tasos | Executive Vice President & CFO | M | Class A Common Stock | 45290 | $0.00 | 167,442.0000 | 324,754,000 | 37.08% | 0.01% |
| March 4, 2026 | Amneal Pharmaceuticals, Inc. | $AMRX | Konidaris Tasos | Executive Vice President & CFO | M | Restricted Stock Units | 49982 | $0.00 | 87,963.0000 | 324,754,000 | 36.23% | 0.02% |
| March 3, 2026 | Amneal Pharmaceuticals, Inc. | $AMRX | Konidaris Tasos | Executive Vice President & CFO | M | Performance-Based Restricted Stock Units | 458716 | $0.00 | 0.0000 | 324,754,000 | 100.00% | 0.14% |
| March 3, 2026 | Amneal Pharmaceuticals, Inc. | $AMRX | Konidaris Tasos | Executive Vice President & CFO | M | Restricted Stock Units | 57339 | $0.00 | 57,340.0000 | 324,754,000 | 50.00% | 0.02% |
| March 2, 2026 | Amneal Pharmaceuticals, Inc. | $AMRX | Konidaris Tasos | Executive Vice President & CFO | A | Performance-Based Restricted Stock Units | 72622 | $0.00 | 72,622.0000 | 324,754,000 | 9999.99% | 0.02% |
| March 2, 2026 | Amneal Pharmaceuticals, Inc. | $AMRX | Konidaris Tasos | Executive Vice President & CFO | A | Restricted Stock Units | 72622 | $0.00 | 72,622.0000 | 324,754,000 | 9999.99% | 0.02% |
| Aug. 15, 2025 | Amneal Pharmaceuticals, Inc. | $AMRX | Konidaris Tasos | Executive Vice President & CFO | S | Class A Common Stock | 219159 | $9.43 | 122,152.0000 | 308,978,000 | 64.21% | 0.07% |
| Aug. 14, 2025 | Amneal Pharmaceuticals, Inc. | $AMRX | Konidaris Tasos | Executive Vice President & CFO | S | Class A Common Stock | 119206 | $9.30 | 341,311.0000 | 308,978,000 | 25.89% | 0.04% |
| Aug. 13, 2025 | Amneal Pharmaceuticals, Inc. | $AMRX | Konidaris Tasos | Executive Vice President & CFO | S | Class A Common Stock | 161365 | $9.22 | 460,517.0000 | 308,978,000 | 25.95% | 0.05% |
| March 5, 2025 | Amneal Pharmaceuticals, Inc. | $AMRX | Konidaris Tasos | Executive Vice President & CFO | S | Class A Common Stock | 100000 | $8.91 | 621,882.0000 | 308,978,000 | 13.85% | 0.03% |
| March 3, 2025 | Amneal Pharmaceuticals, Inc. | $AMRX | Konidaris Tasos | Executive Vice President & CFO | M | Performance-Based Restricted Stock Units | 181159 | $0.00 | 0.0000 | 308,978,000 | 100.00% | 0.06% |
| March 3, 2025 | Amneal Pharmaceuticals, Inc. | $AMRX | Konidaris Tasos | Executive Vice President & CFO | M | Class A Common Stock | 45290 | $0.00 | 595,309.0000 | 308,978,000 | 8.23% | 0.01% |
| March 3, 2025 | Amneal Pharmaceuticals, Inc. | $AMRX | Konidaris Tasos | Executive Vice President & CFO | F | Class A Common Stock | 16373 | $8.76 | 578,936.0000 | 308,978,000 | 2.75% | 0.01% |
| March 3, 2025 | Amneal Pharmaceuticals, Inc. | $AMRX | Konidaris Tasos | Executive Vice President & CFO | M | Class A Common Stock | 57340 | $0.00 | 636,276.0000 | 308,978,000 | 9.90% | 0.02% |
| March 3, 2025 | Amneal Pharmaceuticals, Inc. | $AMRX | Konidaris Tasos | Executive Vice President & CFO | F | Class A Common Stock | 24374 | $8.76 | 611,902.0000 | 308,978,000 | 3.83% | 0.01% |
| March 3, 2025 | Amneal Pharmaceuticals, Inc. | $AMRX | Konidaris Tasos | Executive Vice President & CFO | M | Class A Common Stock | 181159 | $0.00 | 793,061.0000 | 308,978,000 | 29.61% | 0.06% |
| March 3, 2025 | Amneal Pharmaceuticals, Inc. | $AMRX | Konidaris Tasos | Executive Vice President & CFO | F | Class A Common Stock | 92663 | $8.76 | 700,398.0000 | 308,978,000 | 11.68% | 0.03% |
| March 4, 2025 | Amneal Pharmaceuticals, Inc. | $AMRX | Konidaris Tasos | Executive Vice President & CFO | M | Class A Common Stock | 43981 | $0.00 | 744,379.0000 | 308,978,000 | 6.28% | 0.01% |
| March 4, 2025 | Amneal Pharmaceuticals, Inc. | $AMRX | Konidaris Tasos | Executive Vice President & CFO | F | Class A Common Stock | 22497 | $8.84 | 721,882.0000 | 308,978,000 | 3.02% | 0.01% |
| March 3, 2025 | Amneal Pharmaceuticals, Inc. | $AMRX | Konidaris Tasos | Executive Vice President & CFO | M | Restricted Stock Units | 45290 | $0.00 | 45,290.0000 | 308,978,000 | 50.00% | 0.01% |
| March 3, 2025 | Amneal Pharmaceuticals, Inc. | $AMRX | Konidaris Tasos | Executive Vice President & CFO | M | Restricted Stock Units | 57340 | $0.00 | 114,679.0000 | 308,978,000 | 33.33% | 0.02% |
| March 3, 2025 | Amneal Pharmaceuticals, Inc. | $AMRX | Konidaris Tasos | Executive Vice President & CFO | A | Performance-Based Restricted Stock Units | 228310 | $0.00 | 228,310.0000 | 308,978,000 | 9999.99% | 0.07% |
| March 3, 2025 | Amneal Pharmaceuticals, Inc. | $AMRX | Konidaris Tasos | Executive Vice President & CFO | A | Restricted Stock Units | 114155 | $0.00 | 114,154.0000 | 308,978,000 | 0.00% | 0.04% |
| March 4, 2025 | Amneal Pharmaceuticals, Inc. | $AMRX | Konidaris Tasos | Executive Vice President & CFO | M | Restricted Stock Units | 43981 | $0.00 | 131,945.0000 | 308,978,000 | 25.00% | 0.01% |
| March 1, 2025 | Amneal Pharmaceuticals, Inc. | $AMRX | Konidaris Tasos | Executive Vice President & CFO | M | Class A Common Stock | 36197 | $0.00 | 563,513.0000 | 308,978,000 | 6.86% | 0.01% |
| March 1, 2025 | Amneal Pharmaceuticals, Inc. | $AMRX | Konidaris Tasos | Executive Vice President & CFO | F | Class A Common Stock | 13494 | $8.67 | 550,019.0000 | 308,978,000 | 2.39% | 0.00% |
| March 1, 2025 | Amneal Pharmaceuticals, Inc. | $AMRX | Konidaris Tasos | Executive Vice President & CFO | M | Restricted Stock Units | 36197 | $0.00 | 0.0000 | 308,978,000 | 100.00% | 0.01% |
| March 12, 2024 | Amneal Pharmaceuticals, Inc. | $AMRX | Konidaris Tasos | Executive Vice President & CFO | M | Restricted Stock Units | 87720 | $0.00 | 0.0000 | 176,136,000 | 100.00% | 0.05% |
| March 12, 2024 | Amneal Pharmaceuticals, Inc. | $AMRX | Konidaris Tasos | Executive Vice President & CFO | M | Class A Common Stock | 87720 | $0.00 | 558,106.0000 | 176,136,000 | 18.65% | 0.05% |
| March 12, 2024 | Amneal Pharmaceuticals, Inc. | $AMRX | Konidaris Tasos | Executive Vice President & CFO | F | Class A Common Stock | 30790 | $5.31 | 527,316.0000 | 176,136,000 | 5.52% | 0.02% |
| March 1, 2024 | Amneal Pharmaceuticals, Inc. | $AMRX | Konidaris Tasos | Executive Vice President & CFO | M | Restricted Stock Units | 36197 | $0.00 | 36,197.0000 | 176,136,000 | 50.00% | 0.02% |
| March 3, 2024 | Amneal Pharmaceuticals, Inc. | $AMRX | Konidaris Tasos | Executive Vice President & CFO | M | Restricted Stock Units | 57339 | $0.00 | 172,019.0000 | 176,136,000 | 25.00% | 0.03% |
| March 3, 2024 | Amneal Pharmaceuticals, Inc. | $AMRX | Konidaris Tasos | Executive Vice President & CFO | M | Restricted Stock Units | 45290 | $0.00 | 90,580.0000 | 176,136,000 | 33.33% | 0.03% |
| March 3, 2024 | Amneal Pharmaceuticals, Inc. | $AMRX | Konidaris Tasos | Executive Vice President & CFO | F | Class A Common Stock | 20126 | $5.47 | 470,386.0000 | 176,136,000 | 4.10% | 0.01% |
| March 3, 2024 | Amneal Pharmaceuticals, Inc. | $AMRX | Konidaris Tasos | Executive Vice President & CFO | M | Class A Common Stock | 57339 | $0.00 | 490,512.0000 | 176,136,000 | 13.24% | 0.03% |
| March 3, 2024 | Amneal Pharmaceuticals, Inc. | $AMRX | Konidaris Tasos | Executive Vice President & CFO | F | Class A Common Stock | 15897 | $5.47 | 433,173.0000 | 176,136,000 | 3.54% | 0.01% |
| March 3, 2024 | Amneal Pharmaceuticals, Inc. | $AMRX | Konidaris Tasos | Executive Vice President & CFO | M | Class A Common Stock | 45290 | $0.00 | 449,070.0000 | 176,136,000 | 11.22% | 0.03% |
| March 1, 2024 | Amneal Pharmaceuticals, Inc. | $AMRX | Konidaris Tasos | Executive Vice President & CFO | F | Class A Common Stock | 13257 | $5.47 | 403,780.0000 | 176,136,000 | 3.18% | 0.01% |
| March 1, 2024 | Amneal Pharmaceuticals, Inc. | $AMRX | Konidaris Tasos | Executive Vice President & CFO | M | Class A Common Stock | 36197 | $0.00 | 417,037.0000 | 176,136,000 | 9.50% | 0.02% |
| March 4, 2024 | Amneal Pharmaceuticals, Inc. | $AMRX | Konidaris Tasos | Executive Vice President & CFO | A | Performance-Based Restricted Stock Units | 351852 | $0.00 | 351,852.0000 | 176,136,000 | 9999.99% | 0.20% |
| March 4, 2024 | Amneal Pharmaceuticals, Inc. | $AMRX | Konidaris Tasos | Executive Vice President & CFO | A | Restricted Stock Units | 175926 | $0.00 | 175,926.0000 | 176,136,000 | 9999.99% | 0.10% |
| March 12, 2023 | Amneal Pharmaceuticals, Inc. | $AMRX | Konidaris Tasos | Executive Vice President & CFO | M | Restricted Stock Units | 87719 | $0.00 | 87,720.0000 | 150,944,000 | 50.00% | 0.06% |
| March 12, 2023 | Amneal Pharmaceuticals, Inc. | $AMRX | Konidaris Tasos | Executive Vice President & CFO | M | Class A Common Stock | 87719 | $0.00 | 380,840.0000 | 150,944,000 | 29.93% | 0.06% |
| March 3, 2023 | Amneal Pharmaceuticals, Inc. | $AMRX | Konidaris Tasos | Executive Vice President & CFO | M | Restricted Stock Units | 45289 | $0.00 | 135,870.0000 | 150,944,000 | 25.00% | 0.03% |
| March 3, 2023 | Amneal Pharmaceuticals, Inc. | $AMRX | Konidaris Tasos | Executive Vice President & CFO | M | Class A Common Stock | 45289 | $0.00 | 293,121.0000 | 150,944,000 | 18.27% | 0.03% |
| March 3, 2023 | Amneal Pharmaceuticals, Inc. | $AMRX | Konidaris Tasos | Executive Vice President & CFO | A | Performance-Based Restricted Stock Units | 458716 | $0.00 | 458,716.0000 | 150,944,000 | 9999.99% | 0.30% |
| March 3, 2023 | Amneal Pharmaceuticals, Inc. | $AMRX | Konidaris Tasos | Executive Vice President & CFO | A | Restricted Stock Units | 229358 | $0.00 | 229,358.0000 | 150,944,000 | 9999.99% | 0.15% |
| March 1, 2023 | Amneal Pharmaceuticals, Inc. | $AMRX | Konidaris Tasos | Executive Vice President & CFO | M | Class A Common Stock | 36197 | $0.00 | 247,832.0000 | 150,944,000 | 17.10% | 0.02% |
| March 1, 2023 | Amneal Pharmaceuticals, Inc. | $AMRX | Konidaris Tasos | Executive Vice President & CFO | M | Restricted Stock Units | 36197 | $0.00 | 72,394.0000 | 150,944,000 | 33.33% | 0.02% |